Author

Almea M. Matanock

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Aug 2026

Ethiopia missed opportunities for vaccination study: Cluster-randomized evaluation of 5-dose measles vaccine vials and a flexible open-vial policy, 2021–2022

Introduction: In 2024, an estimated 95,000 people died from measles globally, largely from suboptimal coverage with the measles-containing vaccine (MCV). Health workers may defer vaccinating eligible children to avoid wasting doses from 10-dose MCV vials, which must be discarded six hours after opening. These missed op...

A. Wallace, Ciara E. Sugerman, Bezawit A. Getachew et al. · Vaccine · 0 citations

Review Open access Oct 2026

Timeliness of measles vaccination in selected districts of Oromia Region, Ethiopia - 2021.

Background Delays in vaccination with the first/second dose of measles-containing vaccine (MCV1, MCV2) increases risk of measles transmission. MCV2 was added to Ethiopia's routine immunization schedule in 2019, administered at age 15 months. We describe age at measles vaccination and characteristics associated with tim...

Monica P. Shah, A. B. Woyessa, Almea M. Matanock et al. · Vaccine: X · 0 citations